Aquestive Therapeutics (AQST) Shares Outstanding (Diluted) (2020 - 2026)
Aquestive Therapeutics (AQST) Shares Outstanding (Diluted) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Dil.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.76 Bn | 42.79 Bn | - | 4.46 Bn |
| 2 | Teva Pharmaceutical Industries | 43.38 Bn | 39.73 Bn | 2.15 Bn | 1.17 Bn |
| 3 | Zoetis | 31.61 Bn | 29.93 Bn | 1.05 Bn | 417.70 Mn |
| 4 | Takeda Pharmaceutical | 28.64 Bn | 22.84 Bn | 5.10 Bn | 1.58 Bn |
| 5 | United Therapeutics | 22.20 Bn | 19.54 Bn | 683.80 Mn | 45.80 Mn |
| 6 | Viatris | 18.82 Bn | 17.93 Bn | 1.46 Bn | 1.16 Bn |
| 7 | Neurocrine Biosciences | 15.67 Bn | 15.28 Bn | 935.80 Mn | 104.20 Mn |
| 8 | Elanco Animal Health | 12.11 Bn | 11.58 Bn | 798.00 Mn | 505.90 Mn |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - | 833.33 Mn |
| 10 | Aquestive Therapeutics | 558.10 Mn | 558.10 Mn | 9.80 Mn | 124.99 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 124.99 Mn |
| Mar 31, 2026 | 122.61 Mn |
| Dec 31, 2025 | 106.93 Mn |
| Sep 30, 2025 | 110.58 Mn |
| Jun 30, 2025 | 99.33 Mn |
| Mar 31, 2025 | 95.50 Mn |
| Dec 31, 2024 | 86.73 Mn |
| Sep 30, 2024 | 91.08 Mn |
| Jun 30, 2024 | 90.91 Mn |
| Mar 31, 2024 | 73.61 Mn |
| Dec 31, 2023 | 61.26 Mn |
| Sep 30, 2023 | 64.68 Mn |
| Jun 30, 2023 | 57.35 Mn |
| Mar 31, 2023 | 73.79 Mn |
| Dec 31, 2022 | 48.73 Mn |
| Sep 30, 2022 | 53.42 Mn |
| Jun 30, 2022 | 45.46 Mn |
| Mar 31, 2022 | 41.47 Mn |
| Dec 31, 2021 | 38.08 Mn |
| Sep 30, 2021 | 39.22 Mn |